Finally, with additional studies with larger samples and the development of third-generation radiotracers that can overcome the rs6971 polymorphism, PET radiotracers targeting TSPO have a promising future in the study of PD and other neurodegenerative disorders. This evidence concerns the gene TSPO and Parkinson disease.